|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
59,420,000 |
Market
Cap: |
N/A |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$ - $ |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Generation Bio is a genetic medicines company providing durable, redosable treatments for potentially various of patients living with rare and prevalent diseases. Co.'s non-viral genetic medicine platform incorporates its DNA construct called closed-ended DNA; its cell-targeted lipid nanoparticle delivery system; and its capsid-free manufacturing process that uses its proprietary cell-free rapid enzymatic synthesis, to produce ceDNA. Using Co.'s platform, it is developing genetic medicines to provide targeted delivery of genetic payloads that include large and multiple genes to a range of cell types across a range of diseases.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
551,455 |
642,217 |
Total Buy Value |
$0 |
$0 |
$778,895 |
$1,265,385 |
Total People Bought |
0 |
0 |
4 |
4 |
Total Buy Transactions |
0 |
0 |
7 |
12 |
Total Shares Sold |
6,719 |
6,719 |
14,725 |
34,618 |
Total Sell Value |
$18,410 |
$18,410 |
$41,694 |
$143,993 |
Total People Sold |
1 |
1 |
2 |
2 |
Total Sell Transactions |
1 |
1 |
4 |
11 |
End Date |
2024-04-07 |
2024-01-05 |
2023-07-07 |
2022-07-07 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Atlas Venture Fund X, L.p. |
10% Owner |
|
2021-03-16 |
4 |
AS |
$0.00 |
$0 |
D/D |
(1,000,000) |
9,111,939 |
|
- |
|
Stanton Matthew |
CHIEF SCIENTIFIC OFFICER |
|
2021-03-10 |
4 |
AS |
$34.57 |
$367,210 |
D/D |
(10,500) |
198,154 |
|
- |
|
Stanton Matthew |
CHIEF SCIENTIFIC OFFICER |
|
2021-03-10 |
4 |
OE |
$0.60 |
$6,300 |
D/D |
10,500 |
208,654 |
|
- |
|
Kerr Douglas |
CHIEF MEDICAL OFFICER |
|
2021-03-05 |
4 |
AS |
$29.68 |
$354,267 |
D/D |
(11,267) |
326,558 |
|
- |
|
Kerr Douglas |
CHIEF MEDICAL OFFICER |
|
2021-03-05 |
4 |
OE |
$4.59 |
$51,716 |
D/D |
11,267 |
337,825 |
|
- |
|
Zimmermann Tracy |
CHIEF DEVELOPMENT OFFICER |
|
2021-03-03 |
4 |
AS |
$41.38 |
$124,140 |
D/D |
(3,000) |
0 |
|
- |
|
Zimmermann Tracy |
CHIEF DEVELOPMENT OFFICER |
|
2021-03-03 |
4 |
OE |
$4.59 |
$13,770 |
D/D |
3,000 |
3,000 |
|
- |
|
Zimmermann Tracy |
CHIEF DEVELOPMENT OFFICER |
|
2021-03-01 |
4 |
AS |
$35.75 |
$97,099 |
D/D |
(2,500) |
0 |
|
- |
|
Zimmermann Tracy |
CHIEF DEVELOPMENT OFFICER |
|
2021-03-01 |
4 |
OE |
$4.59 |
$11,475 |
D/D |
2,500 |
2,500 |
|
- |
|
Mcdonough Geoff |
PRESIDENT AND CEO |
|
2021-03-01 |
4 |
AS |
$36.35 |
$375,801 |
D/D |
(10,000) |
1,194,080 |
|
- |
|
Stanton Matthew |
CHIEF SCIENTIFIC OFFICER |
|
2021-02-10 |
4 |
AS |
$33.59 |
$359,856 |
D/D |
(10,400) |
198,154 |
|
- |
|
Stanton Matthew |
CHIEF SCIENTIFIC OFFICER |
|
2021-02-10 |
4 |
OE |
$0.60 |
$6,240 |
D/D |
10,400 |
208,554 |
|
- |
|
Kerr Douglas |
CHIEF MEDICAL OFFICER |
|
2021-02-08 |
4 |
AS |
$33.01 |
$375,954 |
D/D |
(11,267) |
326,558 |
|
- |
|
Kerr Douglas |
CHIEF MEDICAL OFFICER |
|
2021-02-08 |
4 |
OE |
$4.59 |
$51,716 |
D/D |
11,267 |
337,825 |
|
- |
|
Zimmermann Tracy |
CHIEF DEVELOPMENT OFFICER |
|
2021-02-02 |
4 |
AS |
$33.05 |
$82,625 |
D/D |
(2,500) |
0 |
|
- |
|
Zimmermann Tracy |
CHIEF DEVELOPMENT OFFICER |
|
2021-02-02 |
4 |
OE |
$4.59 |
$11,475 |
D/D |
2,500 |
2,500 |
|
- |
|
Angelino Mark D. |
CHIEF OPERATING OFFICER |
|
2021-01-15 |
4 |
AS |
$32.29 |
$247,273 |
D/D |
(7,500) |
345,637 |
|
- |
|
Angelino Mark D. |
CHIEF OPERATING OFFICER |
|
2021-01-15 |
4 |
OE |
$4.59 |
$34,425 |
D/D |
7,500 |
353,137 |
|
- |
|
Zimmermann Tracy |
CHIEF DEVELOPMENT OFFICER |
|
2021-01-14 |
4 |
AS |
$33.09 |
$82,725 |
D/D |
(2,500) |
0 |
|
- |
|
Zimmermann Tracy |
CHIEF DEVELOPMENT OFFICER |
|
2021-01-14 |
4 |
OE |
$4.59 |
$11,475 |
D/D |
2,500 |
2,500 |
|
- |
|
Stanton Matthew |
CHIEF SCIENTIFIC OFFICER |
|
2021-01-14 |
4 |
AS |
$31.11 |
$183,212 |
D/D |
(5,630) |
198,154 |
|
- |
|
Stanton Matthew |
CHIEF SCIENTIFIC OFFICER |
|
2021-01-14 |
4 |
OE |
$0.60 |
$3,378 |
D/D |
5,630 |
203,784 |
|
- |
|
Mcdonough Geoff |
PRESIDENT AND CEO |
|
2021-01-13 |
4 |
GA |
$0.00 |
$0 |
I/I |
275,000 |
275,000 |
|
- |
|
Mcdonough Geoff |
PRESIDENT AND CEO |
|
2021-01-13 |
4 |
GD |
$0.00 |
$0 |
D/D |
275,000 |
1,204,080 |
|
- |
|
Rowland Charles A Jr |
|
|
2021-01-11 |
4 |
B |
$24.50 |
$499,996 |
D/D |
20,408 |
101,035 |
0.01 |
- |
|
294 Records found
|
|
Page 10 of 12 |
|
|